<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03617640</url>
  </required_header>
  <id_info>
    <org_study_id>EKNZ 2015-049</org_study_id>
    <nct_id>NCT03617640</nct_id>
  </id_info>
  <brief_title>Neuro-Immune Interactions in the Gut</brief_title>
  <acronym>NIG</acronym>
  <official_title>The Enteric Nervous System as Modulator of Mucosal Immune Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children's Hospital Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Children's Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inselspital Universität Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kinderspital St. Gallen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bâtiment Hospitalier CHUV</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universität Klinikum Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpitaux Universitaires Genève</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Regionale di Bellinzona e Valli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Children's Hospital Basel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hirschsprung`s disease (HD) is diagnosed shortly after birth and is characterized by the
      presence of megacolon. HD is caused when ganglion cells of the enteric nervous system (ENS)
      in the wall of the large intestine do not develop before birth. This results in a lack of
      gastrointestinal motility and leads to stool obstruction. It is known that ablation of
      enteric nerves is associated with intestinal infection and inflammation. Indeed the most
      severe complication in HD is Hirschsprung`s associated enterocolitis (HAEC), characterized by
      explosive diarrhea, abdominal distension, fever and impending septic shock. Bacteria
      overgrowth and changes in colonic mucosal immune cell populations during HAEC suggest a
      possible defect in mucosal immune homeostasis. Under steady state conditions, the mucosal
      immune system must be tightly controlled to avoid harmful reactions against commensal flora
      and food antigens, while allowing protective immune responses against invading pathogens.
      This balance between tolerance and defense is influenced by the mucosal microenvironment,
      which in turn determines the phenotype and stability of mucosal immune cell populations. The
      goal of this project is to understand if the enteric nervous system plays a role in
      regulating mucosal immunity and how this might contribute to the development of HAEC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hirschsprung`s disease (HD) is diagnosed shortly after birth and is characterized by the
      absence of enteric nerves in parts of colon [Amiel et al.]. Following surgical correction
      many patients develop HD-associated enterocolitis (HAEC), a condition distinguished by
      intestinal inflammation resulting in abdominal distension, severe diarrhea, fever and sepsis
      [Demehri et al.]. The underlying factors leading to HAEC remain poorly understood and likely
      involve a defect in epithelial barrier, including decreased mucin production and insufficient
      immunoglobulin translocation. The establishment of the epithelial barrier is dependent on
      epithelial recognition of microbial products by innate immune receptors, like toll-like
      receptors (TLRs) [Peterson et al.]. TLR-dependent epithelial recognition of microflora also
      coordinates the immune response away from harmless commensal bacteria and towards pathogenic
      invaders. Both innate and adaptive effector cell functions are influenced by
      epithelial-derived signals. Under homeostatic conditions commensal bacteria induce
      anti-inflammatory cytokines in epithelial cells which trigger a tolerogenic phenotype in
      mucosal antigen presenting cells (APC) resulting in generation of commensal-specific
      regulatory T cells (Tregs) [Curotto de Lafaille et al.]. During infection, recognition of
      pathogenic organisms by epithelial cells leads to secretion of inflammatory cytokines thereby
      inducing an inflammatory APC phenotype which promotes T effector cell (Th1, Th17) generation.
      The enteric nervous system is directly located underneath the epithelium and controls
      epithelial cell function. Ablation of enteric glia cells, one of the two cell types of the
      ENS, in mice is associated with inflammation and enterocolitis [Cornet et al.]. In a study
      from 2011 Flamant and co-workers demonstrate that enteric glia cells protect from a shigella
      flexneri invasion by preventing lesions in the epithelial barrier mediated by the glia cell
      derived neurothrophic factor S-nitrosoglutathione (GSNO) [Flamant et al.]. We hypothesize
      that the lack of an enteric nervous system in HD patients modulates the microbial recognition
      of epithelial cells and thereby the phenotype of underlying mucosal APCs and effector T
      cells; this might be associated with the manifestation of HAEC.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 28, 2015</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Phenotypic analysis of immune and nervous cell populations</measure>
    <time_frame>5 years</time_frame>
    <description>Determining cell frequencies and subtypes using fluorescence-activated cell sorting (FACS) and FlowJo software</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expression profil</measure>
    <time_frame>5 years</time_frame>
    <description>RNA expression profile of whole colon tissue and single cell populations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Histological analysis</measure>
    <time_frame>5 years</time_frame>
    <description>Microscopic analysis of colonic tissue using immunofluorescence and immunohistochemistry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbial metagenomics sequencing</measure>
    <time_frame>5 years</time_frame>
    <description>16S/18S/ITS Amplicon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identifying genetic defect</measure>
    <time_frame>5 years</time_frame>
    <description>Targeted Sanger sequencing of known Hirschsprung's disease associated genes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Hirschsprung's Disease Associated Enterocolitis</condition>
  <arm_group>
    <arm_group_label>Hirschsprung's disease patients</arm_group_label>
    <description>Children diagnosed with Hirschsprung's disease or Hirschsprung's disease associated enterocolitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control patients</arm_group_label>
    <description>Children diagnosed and treated for miscellaneous bowel diseases</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  colonic tissue

        -  blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients between 0 and 18 years undergoing bowel resection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Informed consent

        Exclusion Criteria:

        No signed informed consent No blood from patients with weak general state of health
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Holland-Cunz, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simone Keck, PhD</last_name>
    <phone>0041617042813</phone>
    <email>simone.keck@unibas.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan Holland-Cunz, Prof</last_name>
    <phone>0041617042840</phone>
    <email>Stefan.Holland-Cunz@ukbb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kinderchirurgie Universität Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Romero, Dr. med</last_name>
      <phone>00496221566281</phone>
      <email>philipp.romero@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Philipp Romero, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale di Bellinzona e Valli</name>
      <address>
        <city>Bellinzona</city>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Mendoza Sagaon, Dr. med</last_name>
      <phone>0041918119165</phone>
      <email>mario.mendozasagaon@eoc.ch</email>
    </contact>
    <investigator>
      <last_name>Mario Mendoza Sagaon, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital Universität Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dietmar Cholewa, Dr. med.</last_name>
      <phone>0041316329256</phone>
      <email>Dietmar.Cholewa@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Dietmar Cholewa, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires Genève</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Wildhaber, Prof</last_name>
      <phone>0041223724663</phone>
      <email>Barbara.wildhaber@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Barbara Wildhaber, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bâtiment Hospitalier CHUV</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleuthere Stathopoulos, Dr. med</last_name>
      <phone>004179 556 82 57</phone>
      <email>Eleuthere.Stathopoulos@chuv.ch</email>
    </contact>
    <investigator>
      <last_name>Blaise-Julien Meyrat, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Luzerner Kantonsspital</name>
      <address>
        <city>Luzern</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Szavay, Dr. med</last_name>
      <phone>0041412053155</phone>
      <email>philipp.szavay@luks.ch</email>
    </contact>
    <investigator>
      <last_name>Philipp Szavay, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinderspital St. Gallen</name>
      <address>
        <city>Saint Gallen</city>
        <zip>9000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Krebs, Dr. med</last_name>
      <phone>0041712437502</phone>
      <email>thomas.krebs@kispisg.ch</email>
    </contact>
    <investigator>
      <last_name>Thomas Krebs, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinderspital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sasha Tharakan, Dr. med</last_name>
      <phone>0041 44 266 7111</phone>
      <email>Sasha.Tharakan@kispi.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Sasha Tharakan, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet. 2001 Nov;38(11):729-39. Review.</citation>
    <PMID>11694544</PMID>
  </reference>
  <reference>
    <citation>Demehri FR, Halaweish IF, Coran AG, Teitelbaum DH. Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention. Pediatr Surg Int. 2013 Sep;29(9):873-81. doi: 10.1007/s00383-013-3353-1. Review.</citation>
    <PMID>23913261</PMID>
  </reference>
  <reference>
    <citation>Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014 Mar;14(3):141-53. doi: 10.1038/nri3608. Review.</citation>
    <PMID>24566914</PMID>
  </reference>
  <reference>
    <citation>Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 2009 May;30(5):626-35. doi: 10.1016/j.immuni.2009.05.002. Review.</citation>
    <PMID>19464985</PMID>
  </reference>
  <reference>
    <citation>Cornet A, Savidge TC, Cabarrocas J, Deng WL, Colombel JF, Lassmann H, Desreumaux P, Liblau RS. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13306-11. Epub 2001 Oct 30.</citation>
    <PMID>11687633</PMID>
  </reference>
  <reference>
    <citation>Flamant M, Aubert P, Rolli-Derkinderen M, Bourreille A, Neunlist MR, Mahé MM, Meurette G, Marteyn B, Savidge T, Galmiche JP, Sansonetti PJ, Neunlist M. Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione. Gut. 2011 Apr;60(4):473-84. doi: 10.1136/gut.2010.229237. Epub 2010 Dec 7.</citation>
    <PMID>21139062</PMID>
  </reference>
  <reference>
    <citation>Rusmini M, Griseri P, Lantieri F, Matera I, Hudspeth KL, Roberto A, Mikulak J, Avanzini S, Rossi V, Mattioli G, Jasonni V, Ravazzolo R, Pavan WJ, Pini-Prato A, Ceccherini I, Mavilio D. Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients. PLoS One. 2013;8(3):e59066. doi: 10.1371/journal.pone.0059066. Epub 2013 Mar 18. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/d3a96ff5-2a66-4454-8d8d-932ad4cfe906.</citation>
    <PMID>23527089</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>July 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>July 31, 2018</last_update_submitted>
  <last_update_submitted_qc>July 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Children's Hospital Basel</investigator_affiliation>
    <investigator_full_name>Simone Keck</investigator_full_name>
    <investigator_title>Dr. Simone Keck</investigator_title>
  </responsible_party>
  <keyword>enteric neuropathies</keyword>
  <keyword>Immune cells</keyword>
  <keyword>Nervous cells</keyword>
  <keyword>Microbiom</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Hirschsprung Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

